CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

ClinicalTrials.gov ID: NCT05958342

Public ClinicalTrials.gov record NCT05958342. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 9, 2026, 6:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The CAlcium and VAsopressin following Injury Early Resuscitation (CAVALIER) Trial is a proposed 4 year, double-blind, mutli-center, prehospital and early in hospital phase randomized trial designed to determine the efficacy and safety of prehospital calcium and early in hospital vasopressin in patients at risk of hemorrhagic shock.

Study identification

NCT ID: NCT05958342
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Jason Sperry; Other
Enrollment: 1,050 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years to 90 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 29, 2024
Primary completion: Feb 28, 2027
Completion: Feb 29, 2028
Last update posted: Aug 5, 2026

2024 – 2028

United States locations

U.S. sites: 16
U.S. states: 13
U.S. cities: 14

Facility	City	State	ZIP	Site status
Chandler Regional Medical Center	Chandler	Arizona	85224	Recruiting
University of Arizona	Tucson	Arizona	85724	Recruiting
University of Arkansas for Medical Sciences	Little Rock	Arkansas	72205	Recruiting
Zuckerberg San Francisco General Hospital and Trauma Center at University of California, San Francisco	San Francisco	California	94110	Recruiting
Denver Health Medical Center	Denver	Colorado	80204	Recruiting
University of Miami	Miami	Florida	33136	Recruiting
University of Maryland, Baltimore	Baltimore	Maryland	21201	Recruiting
Hennepin County Medical Center	Minneapolis	Minnesota	55415	Recruiting
University of Missouri Health Care	Columbia	Missouri	65202	Recruiting
University of New Mexico	Albuquerque	New Mexico	87131	Recruiting
The Ohio State University Wexner Medical Center	Columbus	Ohio	43210	Recruiting
Mount Carmel East Hospital	Columbus	Ohio	43213	Recruiting
Allegheny Health Network	Pittsburgh	Pennsylvania	15212	Recruiting
University of Pittsburgh	Pittsburgh	Pennsylvania	15213	Recruiting
Texas Tech University Health Sciences Center	Lubbock	Texas	79430	Recruiting
University of Washington Harborview Medical Center	Seattle	Washington	98104	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05958342, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 5, 2026 · Synced Sep 9, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05958342 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →